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Aims
1. To find predictors of progression to RA in a cohort of
patients with a very recent onset polyarthritis. 2. To test
the performance of the new ACR/EULAR criteria for
the classification of RA in this population.
Patients
Patients with polyarthritis with less than 6 weeks of
duration were enrolled during a period of 4 years. They
were not exposed previously to corticosteroids or
DMARDs. All patients were prospectively followed-up
in order to establish a definitive clinical diagnosis.
A protocol was applied, including demographic and clin-
ical data, and a blood sample was collected to assess
ESR, RF and ACPA levels, before any treatment was
started.
Results
Thirty-seven patients were included. During the follow
up most of the patients evolved into RA (57%). The
median age of the patients of the RA-group was similar
to the median age of the non-RA group (median (IQR)
47 (31-58.5) vs 43 (34-69) years, p=0.74). At the initial
visit the DAS 28 in the RA group was significantly
higher than in the non-RA group, as well as the VAS
and the number of swollen joints. The ESR values did
not differ significantly between RA and non-RA groups
(Table 1).
Among the 21 RA patients, 21 were evaluated for RF
and 17 for ACPA in the first visit. Of these, 45% pre-
sented RF and 37.5% presented ACPA. RF and ACPA
were not detectable in any of the patients who did not
evolve to RA.
According to the new criteria for the classification of
RA, the mean total score of the RA group at baseline was
significantly higher than the non-RA group (median
(IQR) 6 (4.5-8) vs 4.5 (2.2-6), p=0,007). Interestingly, the
highest score reached in the non-RA patients was 6
points, the cut-off point to classify patients as having RA.
Conclusion
In our cohort a high DAS28 score, a high number of
swollen joints, a low functional status and the presence
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Table 1 Baseline differences between patients who latter
evolved into RA (RA-group), comparing to who did not
(non-RA group)
Parameter RA Non-RA p-value
DAS28 6.2 (4.9-7.3) 4.8 (3.8-5.9) 0.016*
VAS 60 (50-89.5) 46 (30-60) 0.045*
Swollen joints 8 (3-20) 2 (0-9.7) 0.042*
Tender joints 10 (3-20) 5.5 (2-17.7) 0.202
Total involved joints 12 (8-18) 10.5 (3.5-18) 0.380
CRP 2.74 (1.7-4.3) 2.1 (0.1-4.8) 0.810
ESR 37 (26.5-63.5) 25 (19.5-60) 0.419
HAQ 1.9 (1-2) 0.87 (0.25-1) 0.020*
*p-value <0.05; DAS28: Disease Activity Score 28; VAS: Visual Analogue Scale;
ESR: Erythrocyte sedimentation rate; HAQ: Health Assessment Questionnaire;
RA: Rheumatoid arthritis. Values are expressed as median and interquartile
range: median (IQR).
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© 2010 Mourão et al; licensee BioMed Central Ltd.of RF or ACPA are associated with the future evolution
into RA. The new ACR/EULAR criteria for the classifi-
cation of RA seem to identify the majority of patients
that will evolve to RA.
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